Cardiovascular safety of melatonin: insights from nationwide Danish registries

28 August 2026 (15:15 - 15:40)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Daniel Molager Christensen

Herlev Hospital, Herlev (Denmark)

3 More presentations in this session

Presentation thumbnail

Unveiling the mechanism of BDKRB2-mediated protection against hypertension induced by apatinib: a time-series transcriptomic study

Ms Y. Sun (Dalian, CN)

Abstract Slides

Presentation thumbnail

Mechanisms of TNF-α-mediated myocardial toxicity induced by CAR-T cell therapy

Professor W. Gao (Jinan, CN)

Presentation thumbnail

Cardiovascular safety of bexarotene in mycosis fungoides: a propensity-matched analysis of 2,598 patients

Associate Professor C. Filippatos (Athens, GR)

Abstract Slides

Access the full session

Session thumbnail

Cardiovascular safety, toxicity, and protection across modern pharmacotherapies

The Event

Event poster

ESC Congress 2026

28 August 2026 15:15 CET

You may be interested in

Congress Presentation

Do sleep aids differ in cardiac safety? A comparative eudravigilance analysis of melatonin and zolpidem arrhythmia reports

14 April 2026

Congress Presentation

The association between long-term statin use and cataract in both primary and secondary prevention of cardiovascular disease - a nationwide, cohort study on 597,605 cataract patients

26 August 2022

Congress Presentation

Are antidepressants safe in patients with heart failure?

20 May 2023

Congress Presentation

Cardiovascular outcomes evaluation in a cohort of patients with neuroendocrine tumors and carcinoid syndrome

21 June 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources